| Typicality: | 0.389 |
| Saliency: | 0.327 |
| in this clinical trial protocol | 3 | location |
| mood → stabilizer as → valproate | 5 |
| mood → stabilizer as → valproic acid | 4 |
| mood → stabilizer → valproate | 3 |
| negative | neutral | positive |
| 0.114 | 0.779 | 0.107 |
| Raw frequency | 12 |
| Normalized frequency | 0.327 |
| Modifier score | 0.500 |
| Perplexity | 166.899 |